Stay updated on Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page.

Latest updates to the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page
- CheckyesterdayChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check15 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations related to Huntington's disease and drug safety, while removing previous location details and references to Huntington Disease.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to include detailed information about a clinical trial for Huntington's Disease, including study design, eligibility criteria, and locations of the study sites. Additionally, a disclaimer regarding the review of studies by the U.S. government has been added.SummaryDifference100%
Stay in the know with updates to Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page.